Legend: : Special Mention : Important ![]() : Very Important ![]() ![]() : Key Development |
||
| Enzyme therapy for management of coeliac disease. HJ Cornell, FA Macrae, J Melny, CJ Pizzey, F Cook, S Mason, PS Bhathal, T Stelmasiak, Scand J Gastroenterol. 2005 Nov:1304-12 |
||
| Glucagon-like peptide-2: update of the recent clinical trials. PB Jeppesen, Gastroenterology. 2006 Feb:S127-31 |
||
| Supplementary evidence: | ||
| Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. P Collin, K Kaukinen, H Vogelsang, I Korponay-Szabó, R Sommer, E Schreier, U Volta, A Granito, L Veronesi, F Mascart, A Ocmant, A Ivarsson, C Lagerqvist, A Burgin-Wolff, F Hadziselimovic, RI Furlano, MA Sidler, CJ Mulder, MS Goerres, ML Mearin, MK Ninaber, E Gudmand-Høyer, E Fabiani, C Catassi, H Tidlund, L Alainentalo, M Mæki, Eur J Gastroenterol Hepatol. 2005 Jan:85-91 |
||
| Evidence for increased apoptosis of duodenal intraepithelial lymphocytes in cow's milk sensitive enteropathy. MT Augustin, J Kokkonen, TJ Karttunen, J Pediatr Gastroenterol Nutr. 2005 Mar:352-8 |
||
| Given capsule endoscopy in celiac disease: evaluation of diagnostic accuracy and interobserver agreement. R Petroniene, E Dubcenco, JP Baker, CA Ottaway, SJ Tang, SA Zanati, CJ Streutker, GW Gardiner, RE Warren, KN Jeejeebhoy, Am J Gastroenterol. 2005 Mar:685-94 |
||
| Intestinal permeability in long-term follow-up of patients with celiac disease on a gluten-free diet. DR Duerksen, C Wilhelm-Boyles, DM Parry, Dig Dis Sci. 2005 Apr:785-90 |
||
| Nutritional supplements used in weight-reduction programs increase intestinal gas in persons who malabsorb lactose. FL Suarez, LM Zumarraga, JK Furne, MD Levitt, J Am Diet Assoc. 2001 Dec:1447-52 |
||
| Oats to children with newly diagnosed coeliac disease: a randomised double blind study. L H&oeig;gberg, P Laurin, K Fælth-Magnusson, C Grant, E Grodzinsky, G Jansson, H Ascher, L Browaldh, JA Hammersj&oeig;, E Lindberg, U Myrdal, L Stenhammar, Gut. 2004 May:649-54 |
||
| Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests. MR Akbari, A Mohammadkhani, H Fakheri, M Javad Zahedi, B Shahbazkhani, M Nouraie, M Sotoudeh, R Shakeri, R Malekzadeh, Eur J Gastroenterol Hepatol. 2006 Nov:1181-6 |
||
| The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. BM Paterson, KM Lammers, MC Arrieta, A Fasano, JB Meddings, Aliment Pharmacol Ther. 2007 Sep 1:757-66 |
||